This is the logo of the provider
EASD 2025 15 - 19 September 2025

Assessing thyroid cancer risk: GLP-1 RA shows short to intermediate-term safety

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Diabetes
Congress short oral presentation
GLP-1 RA
Semaglutide
Semaglutide (oral)
Liraglutide
Other